- Home
- DNLI vs CPRX Comparison
DNLI vs CPRX Comparison
Compare DNLI & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- CPRX
- Stock Information
- Founded
- DNLI 2013
- CPRX 2002
- Country
- DNLI United States
- CPRX United States
- Employees
- DNLI N/A
- CPRX N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- DNLI Health Care
- CPRX Health Care
- Exchange
- DNLI Nasdaq
- CPRX Nasdaq
- Market Cap
- DNLI 2.5B
- CPRX 2.9B
- IPO Year
- DNLI 2017
- CPRX 2006
- Fundamental
- Price
- DNLI $19.09
- CPRX $23.60
- Analyst Decision
- DNLI Strong Buy
- CPRX Strong Buy
- Analyst Count
- DNLI 13
- CPRX 5
- Target Price
- DNLI $32.64
- CPRX $32.60
- AVG Volume (30 Days)
- DNLI 1.4M
- CPRX 1.4M
- Earning Date
- DNLI 11-06-2025
- CPRX 11-05-2025
- Dividend Yield
- DNLI N/A
- CPRX N/A
- EPS Growth
- DNLI N/A
- CPRX 44.94
- EPS
- DNLI N/A
- CPRX 1.71
- Revenue
- DNLI N/A
- CPRX $578,196,000.00
- Revenue This Year
- DNLI N/A
- CPRX $16.59
- Revenue Next Year
- DNLI $94,232.03
- CPRX $8.42
- P/E Ratio
- DNLI N/A
- CPRX $13.81
- Revenue Growth
- DNLI N/A
- CPRX 25.56
- 52 Week Low
- DNLI $10.57
- CPRX $19.05
- 52 Week High
- DNLI $26.18
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- DNLI 69.43
- CPRX 68.58
- Support Level
- DNLI $16.85
- CPRX $22.23
- Resistance Level
- DNLI $18.21
- CPRX $23.62
- Average True Range (ATR)
- DNLI 1.17
- CPRX 0.88
- MACD
- DNLI 0.23
- CPRX 0.09
- Stochastic Oscillator
- DNLI 90.65
- CPRX 88.96
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).